AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2642-9756/166
1 Cardiac science, King Saud University, Riyadh, Saudi Arabia.
2 Anatomy department, King Saud University, Riyadh, Saudi Arabia.
*Corresponding Author: Hessah Alshammari, Msc, PhD Assistant professor, Cardiac science, King Saud University Riyadh, Saudi Arabia.
Citation: Hessah F. Alshammari, Al-Rabiah AH, Sameerah Y. Shaheen, Sarah I. Mazi, Rakia S. Aljasser, (2023), Menstrual Cycle Changes after the Covid-19 Vaccine: a Case-Control Study in Saudi Arabia, J. Women Health Care and Issues. 6(6); DOI:10.31579/2642-9756/166
Copyright: © 2023, Hessah Alshammari. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 28 August 2023 | Accepted: 11 September 2023 | Published: 04 October 2023
Keywords: COVID-19; COVID-19 vaccine; menstrual cycle
Background
Various side effects of the COVID-19 vaccine, such as fatigue, have been reported. However, there has been a recent increase in reports of menstrual cycle changes among women. This study assessed the effect of the COVID-19 vaccine on the menstrual cycle of Saudi women.
Material & Methods
In this case-control study, data were based on an interview questionnaire used to collect all the requested information. Data were collected between November–December 2021 from 500 healthy Saudi females between 20–40 years. We included all women who reported having a normal menstrual cycle before being vaccinated against COVID-19.
Result
A total of 65.6% of participants reported having significant changes in their cycle in terms of period timing, blood flow, and pain following the first and 65.6.% following the second COVID-19 vaccination doses. Both the mRNA and adenovirus vectored COVID-19 vaccines affected the cycle similarly. The induced COVID-19 vaccine menstrual cycle abnormality is a short-term effect lasting less than three months after the first and second dose.
Conclusion
There are reported side effects of the COVID-19 vaccine, however, changes in the menstrual cycle have not been reported. Our study assume that the menstrual cycle changes observed in study’s participants were unlikely to be caused by reasons other than the COVID-19 vaccine, since we excluded all participants with medical interventions, medical conditions, and the age range that might affect the menstrual cycle. Although this effect is a short-term effect, the exact mechanism behind this phenomenon must be investigated.
The World Health Organization (WHO) announced the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV-2; also known as COVID-19) on March 11, 2020. COVID-19 originated in Asia and spread worldwide [1]. The latest WHO update shows that there are approximately 250 million confirmed cases and 5 million deaths worldwide due to COVID-19 (1). COVID-19 became a global pandemic and caused a worldwide crisis that led to international lockdowns of different levels of stringency [1]. Several methods were implemented to prevent the spread of the virus, including quarantine, social distancing, disinfection drives, and the use of protective masks. These procedures have had an adverse psychological and economic impact and have led to controversies between the healthcare community and political decision-makers [2]. Therefore, rapid progress was made in terms of exploring the genomic sequence of the viral RNA, diagnostic tools, experimental treatments, and methods of protection from SARS-CoV-2. Although several potential therapies with promising results were being developed to treat severe forms of COVID‑19, restrictions were applied to prevent the spread of the virus, and antiviral treatments were utilized to address public health needs [2].
By September 2020, pharmaceutical companies worldwide were competing in the development and commercialization of effective COVID-19 vaccines, with over 124 vaccine proposals employing various strategies to design and produce the vaccine. Of these, only 10 vaccines successfully reached the phase 1 trial stage [2]. Various vaccines have been approved by the United States Food and Drug Administration and have been distributed and used worldwide. Among these, only the Pfizer and AstraZeneca vaccines were initially approved and used in Saudi Arabia. The Pfizer/BioNTech vaccine (BNT162b2) uses mRNA viruses to encode the modified spike protein stabilized in its pre-fusion conformation. The Oxford–AstraZeneca vaccine is a chimpanzee adenovirus-vectored vaccine ChAdOx1 nCoV-19 (AZD1222) [3]. Both vaccines have been effective and safe in preventing COVID-19 in clinical trials and are now used worldwide [1].
There is considerable interest in exploring the effect of various COVID-19 vaccines on the human body [4]. Numerous researchers are investigating different side effects of the COVID‑19 vaccine such as fever, headache and vaccine-induced cross-reactivity in specific disease conditions. The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has reported some common side effects of the COVID-19 vaccine, such as a sore arm, fever, and fatigue (from the weekly summary of yellow card reporting). However, primary care clinicians and reproductive health workers have been continuously reporting changes in the menstrual cycle of women, including unexpected bleeding [4]. One study has linked the COVID-19 vaccine to an increased menstrual cycle length in women [5]. An investigation of the possible connection between COVID-19 vaccines and menstrual changes may enhance our understanding of the mechanism and thereby help prevent this adverse effect.
A recent cohort study that included U.S. residents, aged 18–45 years, with normal menstrual cycle lengths, investigated their menstrual cycle data using the “Natural Cycles” application for three cycles before the vaccine dose and one cycle after receiving the vaccine. They also compared vaccinated and unvaccinated women. This study reported that the COVID-19 vaccination leads to a small change in the cycle length but not in the length of menses [5]. Reports on social media about the disturbance of the menstrual cycle after the COVID-19 vaccination may also lead to vaccine hesitancy [6].
The menstrual cycle is considered a sensitive vital sign in women, a marker of possible underlying medical conditions, and an effective tool to assess hormonal development normalcy and exclude dangerous abnormalities, such as inflammatory bowel disease [7]. Unfortunately, all of the current trials on the COVID-19 vaccines did not study the effect of the vaccines on the menstrual cycle, and only a small number of women had self-reported menstruation-related changes in response to the vaccines. Therefore, it is very important to investigate the effects and characterize the changes in the menstrual cycle that occured after the COVID-19 vaccine. The findings of this investigation may help women in overcoming their hesitancy and fears that the COVID-19 vaccine may disrupt their hormone levels. Successful COVID-19 vaccination programs rely on clear research findings on the adverse effects of the COVID-19 vaccines.
The present study aimed to investigate the association between the COVID-19 vaccines and the occurrence of menstrual cycle changes and to determine the adverse effects of the vaccine on the menstrual cycle of Saudi women. Furthermore, the study aimed to confirm whether the COVID-19 vaccine-related adverse effects are short-term or long-term. This will help women plan for potentially altered cycles. Collectively, this study aims to help clarify the doubts that women have by providing them with robust information about the COVID-19 vaccine, which can help them overcome their apprehensions regarding the vaccine.
This case-control study, conducted between November and December 2021, quantitatively assessed the effect of the COVID-19 vaccine on the menstrual cycle of women in Saudi Arabia. The estimated sample size (n= 500) was derived from the online Raosoft sample size calculator and this study included a healthy participants who were aged 20–40 years, vaccinated against COVID-19, and reported a normal menstrual cycle before receiving the vaccine. In contrast, women that were pregnant, receiving medications, and those with pre-existing medical conditions were excluded [10].
The data were based on an interview questionnaire used to collect all the requested information from Saudi women. Participation was voluntary and informed consent was obtained from the participants. Participants were recurited from different public areas in universities, hospitals, and malls. A total of 40–50 participants were recrutied from each site. The study adhered to the tenants of the Declaration of Helsinki. In addition, the study was approved by the ethics committee of the King Saud University (approval on Research Project No. E-21-6345).
Aquestionnaire consisting of questions which were either close-ended or multiple choices was used. The questionnaire included information about demographics detials, medication, disease, vaccine, time of vaccine administration, menstrual cycle status before and after vaccination, menstrual irregularity, type of menstrual irregularity (timing, bleeding, and pain), and the time of the observed change [12].
Data were collected in excel 2016 and statistically analyzed by using Statistical Package for Social Studies (SPSS 22; IBM Corp., New York, NY, USA). To assess the relationship between variables, qualitative data was expressed as percentages, and the chi-squared test (χ2) was used. p-value of <0>
Our study included 500 women, all of whom were healthy, aged 20-40 years, and had received two doses of the COVID-19 vaccine (Table 1). Nearly two-thirds of the participants reported an irregularity (in timing, bleeding, and pain) in their menstrual cycle after the first and second doses of the COVID-19 vaccine (Figure 1).
Figure 1: This pie chart displays the percentage of women that had irregular periods after the first (a) and second doses (b) of the COVID-19 vaccine. There is a significant difference between the percentages of women who reported regular and irregular periods after the two doses of the COVID-19 vaccine (p-value < 0>
Irregularity of the Menstrual Cycle
A normal menstrual cycle is characterized by anovulatory cycles, fixed timing of the period, menstrual flow, and pain. In our study, menstrual cycle irregularity was classified, and its percentage was assessed in the study participants that had received two doses of the COVID-19 vaccine. More than one-third of the participants (38% following the first dose and 40% following the second dose) had been experiencing a change in the period timing after the COVID-19 vaccine for either a prolonged or short interval. Around half (52% following both the first and second doses) of the participants reported a change in the amount of bleeding, including excessive menstrual flow. Nearly half of the participants (52% following both the first and second doses) reported changes in the pain associated with their period (Figure 2).
Figure 2: The percentages of menstrual irregularity after the first and second doses of the COVID-19 vaccine. The various types of irregularities involving blood flow, period timing, and pain occurred at a similar rate in women after the first and second dose of the COVID-19 vaccine.
Menstrual Cycle Abnormality After Both the mRNA and Adenovirus-Vectored COVID-19 Vaccines
Among the 500 participants, 78% were vaccinated with BNT162b2, while 21% were vaccinated with AZD1222. Despite the different formulations of
Pfizer (New York, United States of America) and AstraZeneca, both vaccines showed a similar impact on the menstrual cycle, where the p-value was >0.05 (Figure 3).
Figure 3: The menstrual irregularity caused by both the mRNA and adenovirus-vectored COVID-19 vaccines were similar in women, p>0.05.
The menstrual cycle abnormality induced by the COVID-19 vaccine is a short-term effect. After the first dose, 97% of the participants reported that the effect lasted for less than 3 months, and only 3% reported that the effect lasted for 3 months to one year. Furthermore, after the second dose, 96% of the participants reported that the effect lasted for less than 3 months, and only 3.7% reported that the effect lasted for 3 months to one year.
Association Between the Time of the Vaccine and the Menstruation Period
Most participants with an adverse effect did not report the time of the vaccination (if whether it was during their period or after their period), as they could not recall the timing. However, the abnormality in the menstrual cycle was observed in 38% of the participants who reported that the vaccine was not taken during their periods or in the week before their periods, compared to the 45% of participants who reportedly received the vaccine during their period.
Herein, we investigated the type and prevalence of COVID-19 vaccine-related menstrual cycle changes in Saudi women in a case-control study. The number of studies that have linked the COVID-19 vaccine and menstrual cycle abnormalities is relatively low compared to those reporting other vaccine side effects [4]. Our study has added to the existing information on this topic as we confirmed that the COVID-19 vaccine caused irregular menstrual cycles in about 65% of the Saudi women in this study. Importantly, this study aimed to provide an ideal setting to differentiate between the menstrual changes caused by pre-existing medical conditions and those that occur due to the vaccine. Our participants were unlikely to report changes in their menstrual cycle caused by any reason other than the COVID-19 vaccine since the study excluded participants receiving medical interventions, those with pre-existing medical conditions, those in an age range that could affect the menstrual cycle, pregnant women, those with endocrine disorders, polycystic ovary syndrome, hyperprolactinemia, obesity, adrenal and ovarian tumors [8,9]. Additionally, women on insulin, Roctane Electrolyte capsules, hormonal, cardiac, and blood pressure control drugs, and psychotropic medications were excluded [10].
Additionally, this study identified irregularities in the blood flow, period timing, and pain of the menstrual cycle after the COVID-19 vaccine. The menstrual irregularities can either be a single change or combined changes in blood flow, period timing, and pain. Since the participants were between 20–40 years of age, they could seek counsel, recognize abnormal cycle variations, and clearly understand menstrual patterns in terms of blood flow, timing, and pain. Also, the study included only women between 20–40 years of age because women under 20 years of age are adolescents, and abnormal menstrual patterns are expected in adolescents [10], and women over 40 years of age experience menopausal symptoms and are expected to have abnormalities in their menstrual cycle [10].
Furthermore, the menstrual irregularities reported after receiving both the mRNA and adenovirus-vectored COVID-19 vaccines were similar. This might be indicates to a correlation, and the effect is more likely a result of the immune response to the vaccination than to a specific vaccine component. It is well-known that the menstrual cycle can be affected by stimuli related to immune activation, including viral infections. Menstrual cycle changes occur in 25% of the women infected with COVID-19 [11]. In the past, it has been documented that the vaccination against human papillomavirus (HPV) was also linked with menstrual changes [11]. Two concepts explain the biological mechanisms behind the link between menstrual cycle changes and immune stimulation. First, immune stimulation influences the hormones controlling the menstrual cycle [11]. Second, immune cells in the uterus that control the cyclical build-up and breakdown of the endometrium could act as mediators that produce this effect [11]. However, there is still a need to investigate the exact mechanism by which the COVID-19 vaccine affects the menstrual cycle.
Lastly, the menstrual cycle changes induced by the COVID-19 vaccine are short-term, and usually do not last for more than three months. Only 3% of the participants reported that this effect lasted for up to one year. There is COVID-19 vaccine hesitancy among young women due to the misinformation that it could affect their fertility and induce menstrual cycle changes. It has been proved that the COVID-19 vaccination does not affect fertility in women, and clinical trials have reported the same pregnancy rates in vaccinated and unvaccinated groups [8]. Therefore, our study results can help women overcome their fears of vaccination. Also, this important information will particularly help women predict their menstrual cycle after vaccination.
The long period between the first and second dose and the survey time was the key limitation of our study. Also, many participants chose the option “I do not remember” as an answer to some questions, especially the questions regarding the time of receiving the COVID-19 vaccine, where it was hard for participants to remember if it was during, before, or after their period.
The findings reveal that these menstrual irregularities could be either a single change or a combination of changes involving blood flow, period timing, and pain. Additionally, the effects are short-term and occur irrespective of the type of COVID-19 vaccine. A better way to study these effects is to compare the rates of menstrual changes in vaccinated and unvaccinated women; however, this could not be done due to mandatory government regulations. Moreover, this study assessed only the percentage of affected vaccinated women in Saudi Arabia. In the future, COVID-19 vaccine clinical trials should provide information about the effects of the vaccine on the menstrual cycle and possible associated health concerns on females at a global scale. Future studies should aim to monitor participants from the period before the COVID-19 vaccine is received until their menstrual cycle returns to normal. Finally, many participants in our study have reported hair loss and effects on their memory that need to be investigated further.
This research was supported and funded by the authors. We would like to thank Editage.com for English language editing.
The authors have no conflict of interest to disclose.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
